 |
Anagrelide |
|---|---|
| Trade Name | Agrylin |
| Orphan Indication | Thrombocytosis in chronic myelogenous leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1986-07-14 00:00:00 |
| Sponsor | Roberts Pharmaceutical Corp.;Meridian Center II, Four Industrial Way West;Eatontown, New Jersey, 07724 |
